.Merck defeats earnings requirements, increases purchases overview on powerful requirement for best drugs like Keytruda CNBCMerck & Co. (MRK US) Trumps Profit Estimates as Keytruda Sales Rise BloombergMerck Supply: Pharma Titan Posts Tough Results, Yet Overview Drops Short Financier's Company DailyMerck Announces Second-Quarter 2024 Financial Results Yahoo FinanceMerck defeats earnings and sales requirements surrounded by Keytruda asset, however offers mixed full-year overview MarketWatch.